Mediso Medical Imaging Systems is a global leader in the development, manufacturing, and support of multi-modality molecular imaging devices including SPECT/CT, PET/CT, and PET/MRI. Founded in 1990 by experts in a prominent European research and manufacturing company, Mediso has established itself as one of the largest suppliers of medical diagnostic and research imaging devices. The company's product portfolio encompasses a range of imaging modalities - SPECT, PET, CT, and MRI - catering to professionals in laboratory and nuclear medicine departments worldwide.
Mediso's widespread presence is evident through its 1650+ imaging systems operating in over 100 countries across the globe. The company's products are retailed through a network of distributors and direct sales channels. Mediso continues to play a pivotal role in advancing Health Care industries through its cutting-edge technologies and global reach. While specific information regarding the latest investment and investors is not available at this time, Mediso's consistent growth and influence within the medical imaging sector position it as a promising company for potential investment opportunities.
There is no investment information
No recent news or press coverage available for Mediso Medical Imaging Systems.